Edition:
India

Suven Life Sciences Says FDA Observed Some Procedures Are Deficient During Medak Unit Inspection


Tuesday, 24 Apr 2018 

April 24 (Reuters) - Suven Life Sciences Ltd ::SUVEN LIFE SCIENCES - FDA DURING INSPECTION OF PASHAMYLARAM, MEDAK UNIT OBSERVED THERE ARE PROCEDURES FOLLOWED ON CERTAIN ASPECTS WHICH ARE DEFICIENT.SAYS CO REVISED STANDARD OPERATING PROCEDURES AS CORRECTIVE ACTION. 

Company Quote

239.35
-0.75 -0.31%
23 Jul 2019